Bausch Health Companies (TSE:BHC) Trading Up 8.4% After Strong Earnings

Bausch Health Companies Inc. (TSE:BHCGet Free Report)’s stock price traded up 8.4% on Thursday following a stronger than expected earnings report. The company traded as high as C$12.37 and last traded at C$12.33. 36,968 shares were traded during mid-day trading, a decline of 90% from the average session volume of 370,617 shares. The stock had previously closed at C$11.37.

The company reported C$1.53 EPS for the quarter, topping the consensus estimate of C$1.43 by C$0.10. The firm had revenue of C$3.42 billion during the quarter, compared to analyst estimates of C$3.36 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on BHC. Evercore ISI raised Bausch Health Companies to a “hold” rating in a research note on Tuesday, October 15th. Raymond James raised shares of Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.

Get Our Latest Analysis on BHC

Insiders Place Their Bets

In related news, Senior Officer Seana Lynne Carson sold 13,370 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of C$8.38, for a total value of C$112,087.40. Insiders own 11.28% of the company’s stock.

Bausch Health Companies Stock Performance

The stock has a market capitalization of C$4.55 billion, a PE ratio of -7.05, a P/E/G ratio of 0.21 and a beta of 0.77. The firm’s 50 day moving average is C$9.82 and its two-hundred day moving average is C$9.87. The company has a debt-to-equity ratio of 7,583.76, a quick ratio of 0.58 and a current ratio of 1.19.

About Bausch Health Companies

(Get Free Report)

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

See Also

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.